Status:
RECRUITING
Assessing User Satisfaction and Adherence to an Abbreviated Dietary Tracking App (MySnackTracker) Versus Full-intake Dietary Monitoring
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Dietary Monitoring
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To learn if a method of abbreviated food tracking (called MySnackTracker) is a reasonable alternative to traditional full-intake food tracking and to compare the adherence to and acceptability of each...
Detailed Description
Primary Objectives The goal of the study is to compare the adherence and acceptability of tracking only high-energy low-nutrient value foods to standard full intake monitoring of diet. We predict that...
Eligibility Criteria
Inclusion
- Eligibility Criteria
- In order to be eligible to participate in this study, an participants must meet all of the following criteria:
- Provision of signed and dated informed consent form
- Access to internet connection, email address, and smartphone able to download the intervention app
- Current or previous participation in one of the following DFI cohorts: PA17-0584 (MERIT Study), Project CHURCH, High Risk Breast Cohort, Mexican-American Cohort, and rural cancer survivors from the Mind Your BEAT study
- Demonstrated ability to read and understand English. The study app is currently only available in English.
- Exclusion Criteria
- An participant who meets any of the following criteria will be excluded from participation in this study:
- Prisoners
- Anyone currently under 18 years of age
- Cognitively impaired participants
- Pregnant women (assessed by self-report)
- BMI less than 28 or greater than 40
- Self-reported previous or planned bariatric surgery
- Self-reported current or planned use of a GLP-1 agonist medication
- Self-reported current or planned participation in another weight loss intervention
- Cancer participants receiving active treatment
- Anyone currently unable to participate in the research for the duration of the study
- No current motivation to lose weight
Exclusion
Key Trial Info
Start Date :
April 8 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2030
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06919471
Start Date
April 8 2025
End Date
May 1 2030
Last Update
November 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MD Anderson Cancer Center
Houston, Texas, United States, 77030